ARCTIC-GENE throws cold water on genotype-guided antiplatelet therapy at PCI

It's an inspired idea that isn't panning out, at least based on the genetic substudy of a trial looking at platelet-monitoring-guided therapy in coronary stenting: patients with a slow-clopidogrel-metabolization genotype had poorer clopidogrel responses, but therapy adjustments based on that information didn't help clinically.
Source: theHeart.org - Category: Cardiology Source Type: news